Evidence map›Paper›PMID 28464934›Full record

ArticleBMC public health2017

Study protocol of the German Study on Tobacco Use (DEBRA): a national household survey of smoking behaviour and cessation.

Sabrina Kastaun, Jamie Brown, Leonie S Brose, Elena Ratschen, Tobias Raupach, Dennis Nowak, Constanze Cholmakow-Bodechtel, Lion Shahab, Robert West, Daniel Kotz

Abstract read
In one paragraph

Article in BMC public health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Waterpipe and Co-Use of Inhaled Nicotine and Tobacco Products: Findings from a Population-Based Cross-Sectional Household Survey in Germany.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Cannabis Use in Germany.Deutsches Arzteblatt international · 2024
    Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. The Effectiveness of E-Cigarettes for Smoking Cessation.Deutsches Arzteblatt international · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sabrina KastaunInstitute of General Practice, Addiction Research and Clinical Epidemiology Unit, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Werdener Str. 4, 40227, Düsseldorf, Germany. Sabrina.Kastaun@med.uni-duesseldorf.de.
Jamie BrownResearch Department of Clinical, Educational and Health Psychology, University College London, London, United Kingdom.
Leonie S BroseInstitute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Elena RatschenDepartment of Health Sciences, University of York, York, United Kingdom.
Tobias RaupachDepartment of Epidemiology and Public Health, University College London, London, United Kingdom.
Dennis NowakInstitute and Outpatient Clinic for Occupational, Social and Environmental Medicine, Clinical Centre of the Ludwig Maximilian University Munich, Munich, Germany.
Constanze Cholmakow-BodechtelPublic Health and Epidemiology, Clinical and Real World Research, Kantar Health GmbH, Munich, Germany.
Lion ShahabDepartment of Epidemiology and Public Health, University College London, London, United Kingdom.
Robert WestDepartment of Epidemiology and Public Health, University College London, London, United Kingdom.
Daniel KotzInstitute of General Practice, Addiction Research and Clinical Epidemiology Unit, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Werdener Str. 4, 40227, Düsseldorf, Germany.

Funding

Cancer Research UK 19748Medical Research Council MR/K023195/1
6 · The paper itself

Abstract

backgroundThe prevalence of tobacco smoking in Germany is high (~27%). Monitoring of national patterns of smoking behaviour and data on the "real-world" effectiveness of cessation methods are needed to inform policies and develop campaigns aimed at reducing tobacco-related harm. In England, the Smoking Toolkit Study (STS) has been tracking such indicators since 2006, resulting in the adaptation of tobacco control policies. However, findings cannot be directly transferred into the German health policy context. The German Study on Tobacco Use (DEBRA: "Deutsche Befragung zum Rauchverhalten") aims to provide such nationally representative data. METHODS/

designIn June 2016, the study started collecting data from computer-assisted, face-to-face household interviews in people aged 14 years and older. Over a period of 3 years, a total of ~36,000 respondents will complete the survey with a new sample of ~2000 respondents every 2 months (=18 waves). This sample will report data on demographics and the use of tobacco and electronic (e-)cigarettes. Per wave, about 500-600 people are expected to be current or recent ex-smokers (<12 months since quitting). This sample will answer detailed questions about smoking behaviour, quit attempts, exposure to health professionals' advice on quitting, and use of cessation aids. Six-month follow-up data will be collected by telephone. DISCUSSION: The DEBRA study will be an important source of data for tobacco control policies, health strategies, and future research. The methodology is closely aligned to the STS, which will allow comparisons with data from England, a country with one of the lowest smoking prevalence rates in Europe (18%).

trial registrationThis study has been registered at the German Clinical Trials Register ( DRKS00011322 ) on 25th November 2016.

Indexed as

AdolescentAdultAgedBehaviorGermanyHealth SurveysHumansMaleMiddle AgedPrevalenceResearch DesignSmokingSmoking CessationYoung AdultE-CigaretteEpidemiologyGerman Study on Tobacco UseHousehold SurveyTobacco smoking

Identifiers

PMID28464934
PMCPMC5414339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.